About this episode

This episode reviews the OPTIMA-AF trial and its implications for antithrombotic therapy in patients with atrial fibrillation after PCI.

🩺 Can dual antithrombotic therapy after PCI be safely shortened to just 1 month in patients with atrial fibrillation? The OPTIMA-AF trial suggests that an earlier transition to DOAC monotherapy significantly reduces clinically relevant bleeding while maintaining similar protection against death and thromboembolic events. Although the findings require confirmation in broader populations, this study could influence how we individualize antithrombotic therapy after PCI. 🎙️ In this episode of Dr RR Baliga's Podkast for the Kurious Doc , we review the trial, its clinical implications, and the important caveats for everyday practice. #Cardiology #AtrialFibrillation #PCI #MedicalEducation

People in this episode

Host: Dr RR Baliga

Topics covered

• antithrombotic therapy
• atrial fibrillation
• PCI
• clinical implications
• DOAC monotherapy
• bleeding risk
• individualized therapy

Keywords

• dual antithrombotic therapy
• DOAC
• thromboembolic events
• bleeding
• clinical trial
• cardiology
• medical education

Mentioned in this episode

Organizations: OPTIMA-AF trial, Kurios Doc, Cardiology, Medical Education

More episodes of Dr RR Baliga's "Got Knowledge Doc" Podkast

• Great Doctors Series: Zhang Zhongjing—China's Medical Sage · July 21, 2026 · 2 min
• 💊 Twelve More Months of DAPT, Fewer Heart Attacks, No Extra Bleeding · July 19, 2026 · 2 min
• 🛡️ Fountain of Youth, Immune Truth: EP2 Flips the Healthy Aging Switch · July 18, 2026 · 2 min
• 🍏 Whole Fruit Wins: Rethinking Fructose and Blood Pressure · July 17, 2026 · 2 min
• 🧠 Blood p-Tau217: 🩸 A Blood Test That Sees Dementia Coming · July 16, 2026 · 2 min
• Thymus Matters: Cancer, Cardiovascular Risk, Survival ❤️ · July 15, 2026 · 3 min

Explore listener stats, chart rankings, contacts and more on the Dr RR Baliga's "Got Knowledge Doc" Podkast podcast page.